Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Which components are contained in Ultibro Breezhaler?

Ultibro Breezhaler is a fixed-dose inhaler that combines two long-acting bronchodilators: indacaterol and glycopyrronium. Indacaterol is a long-acting beta-2 agonist that relaxes airway smooth muscle by stimulating beta receptors, while glycopyrronium is a long-acting muscarinic antagonist that blocks acetylcholine-mediated bronchoconstriction. Using these two agents together provides ongoing bronchodilation through complementary mechanisms, helping to improve symptoms and reduce COPD exacerbations. Other options mix short-acting agents or include an inhaled corticosteroid, or pair different long-acting agents not specific to this product, so the correct components are indacaterol and glycopyrronium.

Ultibro Breezhaler is a fixed-dose inhaler that combines two long-acting bronchodilators: indacaterol and glycopyrronium. Indacaterol is a long-acting beta-2 agonist that relaxes airway smooth muscle by stimulating beta receptors, while glycopyrronium is a long-acting muscarinic antagonist that blocks acetylcholine-mediated bronchoconstriction. Using these two agents together provides ongoing bronchodilation through complementary mechanisms, helping to improve symptoms and reduce COPD exacerbations. Other options mix short-acting agents or include an inhaled corticosteroid, or pair different long-acting agents not specific to this product, so the correct components are indacaterol and glycopyrronium.